nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—TUBA1A—Vinblastine—hematologic cancer	0.111	0.175	CbGbCtD
Albendazole—ABCB1—hematologic cancer	0.108	1	CbGaD
Albendazole—TUBB4B—Vinorelbine—hematologic cancer	0.0687	0.109	CbGbCtD
Albendazole—TUBB4B—Vinblastine—hematologic cancer	0.0423	0.0669	CbGbCtD
Albendazole—TUBB4B—Vincristine—hematologic cancer	0.0416	0.0657	CbGbCtD
Albendazole—CYP1A2—Anagrelide—hematologic cancer	0.0199	0.0315	CbGbCtD
Albendazole—CYP1A1—Methoxsalen—hematologic cancer	0.0199	0.0315	CbGbCtD
Albendazole—CYP1A1—Bortezomib—hematologic cancer	0.019	0.0299	CbGbCtD
Albendazole—CYP1A1—Daunorubicin—hematologic cancer	0.0181	0.0286	CbGbCtD
Albendazole—CYP1A1—Thalidomide—hematologic cancer	0.0165	0.0261	CbGbCtD
Albendazole—CYP1A1—Dacarbazine—hematologic cancer	0.0142	0.0224	CbGbCtD
Albendazole—ABCB1—Lenalidomide—hematologic cancer	0.0121	0.0191	CbGbCtD
Albendazole—CYP1A1—Dasatinib—hematologic cancer	0.0112	0.0176	CbGbCtD
Albendazole—CYP1A2—Carmustine—hematologic cancer	0.0105	0.0165	CbGbCtD
Albendazole—CYP1A2—Methoxsalen—hematologic cancer	0.00891	0.0141	CbGbCtD
Albendazole—CYP1A2—Bortezomib—hematologic cancer	0.00847	0.0134	CbGbCtD
Albendazole—CYP1A2—Daunorubicin—hematologic cancer	0.0081	0.0128	CbGbCtD
Albendazole—CYP1A2—Alitretinoin—hematologic cancer	0.00794	0.0125	CbGbCtD
Albendazole—CYP1A2—Thalidomide—hematologic cancer	0.00738	0.0117	CbGbCtD
Albendazole—CYP3A4—Bexarotene—hematologic cancer	0.00724	0.0114	CbGbCtD
Albendazole—ABCB1—Daunorubicin—hematologic cancer	0.00709	0.0112	CbGbCtD
Albendazole—ABCB1—Alitretinoin—hematologic cancer	0.00694	0.011	CbGbCtD
Albendazole—CYP3A4—Lomustine—hematologic cancer	0.00673	0.0106	CbGbCtD
Albendazole—CYP3A4—Busulfan—hematologic cancer	0.00673	0.0106	CbGbCtD
Albendazole—CYP1A2—Dacarbazine—hematologic cancer	0.00635	0.01	CbGbCtD
Albendazole—CYP1A2—Imatinib—hematologic cancer	0.00621	0.0098	CbGbCtD
Albendazole—CYP3A4—Thiotepa—hematologic cancer	0.006	0.00948	CbGbCtD
Albendazole—CYP1A1—Dexamethasone—hematologic cancer	0.00572	0.00902	CbGbCtD
Albendazole—ABCB1—Imatinib—hematologic cancer	0.00543	0.00857	CbGbCtD
Albendazole—CYP1A2—Dasatinib—hematologic cancer	0.00499	0.00787	CbGbCtD
Albendazole—ABCB1—Nilotinib—hematologic cancer	0.00493	0.00779	CbGbCtD
Albendazole—ABCB1—Vinorelbine—hematologic cancer	0.00489	0.00772	CbGbCtD
Albendazole—CYP3A4—Methoxsalen—hematologic cancer	0.00467	0.00737	CbGbCtD
Albendazole—CYP3A4—Bortezomib—hematologic cancer	0.00444	0.00701	CbGbCtD
Albendazole—ABCB1—Dasatinib—hematologic cancer	0.00436	0.00688	CbGbCtD
Albendazole—ABCB1—Mitoxantrone—hematologic cancer	0.00431	0.0068	CbGbCtD
Albendazole—CYP3A4—Daunorubicin—hematologic cancer	0.00425	0.0067	CbGbCtD
Albendazole—ABCB1—Betamethasone—hematologic cancer	0.00384	0.00606	CbGbCtD
Albendazole—ABCB1—Gemcitabine—hematologic cancer	0.0038	0.00601	CbGbCtD
Albendazole—ABCB1—Prednisolone—hematologic cancer	0.00379	0.00598	CbGbCtD
Albendazole—CYP3A4—Cytarabine—hematologic cancer	0.00374	0.00591	CbGbCtD
Albendazole—CYP3A4—Teniposide—hematologic cancer	0.00369	0.00582	CbGbCtD
Albendazole—ABCB1—Prednisone—hematologic cancer	0.00358	0.00565	CbGbCtD
Albendazole—CYP3A4—Ifosfamide—hematologic cancer	0.0034	0.00538	CbGbCtD
Albendazole—ABCB1—Irinotecan—hematologic cancer	0.00339	0.00535	CbGbCtD
Albendazole—CYP3A4—Imatinib—hematologic cancer	0.00325	0.00514	CbGbCtD
Albendazole—CYP1A2—Etoposide—hematologic cancer	0.00311	0.0049	CbGbCtD
Albendazole—CYP3A4—Ruxolitinib—hematologic cancer	0.00306	0.00484	CbGbCtD
Albendazole—ABCB1—Vinblastine—hematologic cancer	0.00301	0.00476	CbGbCtD
Albendazole—ABCB1—Vincristine—hematologic cancer	0.00296	0.00468	CbGbCtD
Albendazole—CYP3A4—Nilotinib—hematologic cancer	0.00296	0.00467	CbGbCtD
Albendazole—CYP3A4—Vinorelbine—hematologic cancer	0.00293	0.00463	CbGbCtD
Albendazole—ABCB1—Cisplatin—hematologic cancer	0.00276	0.00436	CbGbCtD
Albendazole—ABCB1—Etoposide—hematologic cancer	0.00272	0.00429	CbGbCtD
Albendazole—CYP3A4—Triamcinolone—hematologic cancer	0.00268	0.00423	CbGbCtD
Albendazole—CYP3A4—Dasatinib—hematologic cancer	0.00261	0.00412	CbGbCtD
Albendazole—CYP3A4—Mitoxantrone—hematologic cancer	0.00258	0.00407	CbGbCtD
Albendazole—CYP3A4—Betamethasone—hematologic cancer	0.0023	0.00363	CbGbCtD
Albendazole—CYP3A4—Prednisolone—hematologic cancer	0.00227	0.00358	CbGbCtD
Albendazole—ABCB1—Dexamethasone—hematologic cancer	0.00223	0.00353	CbGbCtD
Albendazole—TUBA1A—hematopoietic system—hematologic cancer	0.00215	0.0924	CbGeAlD
Albendazole—CYP3A4—Prednisone—hematologic cancer	0.00214	0.00338	CbGbCtD
Albendazole—CYP3A4—Irinotecan—hematologic cancer	0.00203	0.00321	CbGbCtD
Albendazole—ABCB1—Doxorubicin—hematologic cancer	0.00185	0.00292	CbGbCtD
Albendazole—CYP3A4—Vinblastine—hematologic cancer	0.00181	0.00285	CbGbCtD
Albendazole—ABCB1—Methotrexate—hematologic cancer	0.00179	0.00283	CbGbCtD
Albendazole—CYP3A4—Vincristine—hematologic cancer	0.00178	0.0028	CbGbCtD
Albendazole—TUBA1A—gonad—hematologic cancer	0.00163	0.0702	CbGeAlD
Albendazole—CYP3A4—Etoposide—hematologic cancer	0.00163	0.00257	CbGbCtD
Albendazole—TUBB4B—hematopoietic system—hematologic cancer	0.00143	0.0616	CbGeAlD
Albendazole—TUBA1A—blood—hematologic cancer	0.00142	0.0612	CbGeAlD
Albendazole—TUBA1A—bone marrow—hematologic cancer	0.00138	0.0592	CbGeAlD
Albendazole—CYP3A4—Dexamethasone—hematologic cancer	0.00134	0.00211	CbGbCtD
Albendazole—TUBA1A—lung—hematologic cancer	0.00125	0.0536	CbGeAlD
Albendazole—TUBA1A—testis—hematologic cancer	0.00118	0.0506	CbGeAlD
Albendazole—CYP3A4—Doxorubicin—hematologic cancer	0.00111	0.00175	CbGbCtD
Albendazole—TUBB4B—gonad—hematologic cancer	0.00109	0.0468	CbGeAlD
Albendazole—TUBB4B—blood—hematologic cancer	0.000947	0.0408	CbGeAlD
Albendazole—TUBB4B—bone marrow—hematologic cancer	0.000917	0.0395	CbGeAlD
Albendazole—TUBA1A—lymph node—hematologic cancer	0.000852	0.0367	CbGeAlD
Albendazole—TUBB4B—lung—hematologic cancer	0.00083	0.0358	CbGeAlD
Albendazole—CYP1A2—hematopoietic system—hematologic cancer	0.000812	0.0349	CbGeAlD
Albendazole—CYP1A1—hematopoietic system—hematologic cancer	0.000801	0.0345	CbGeAlD
Albendazole—TUBB4B—testis—hematologic cancer	0.000784	0.0337	CbGeAlD
Albendazole—TUBA1A—Vitamin A—Alitretinoin—hematologic cancer	0.000726	0.185	CbGdCrCtD
Albendazole—CYP3A4—hematopoietic system—hematologic cancer	0.000587	0.0253	CbGeAlD
Albendazole—TUBA1A—Zalcitabine—Gemcitabine—hematologic cancer	0.000577	0.147	CbGdCrCtD
Albendazole—TUBA1A—Zalcitabine—Cytarabine—hematologic cancer	0.000577	0.147	CbGdCrCtD
Albendazole—TUBB4B—lymph node—hematologic cancer	0.000568	0.0245	CbGeAlD
Albendazole—CYP1A2—blood—hematologic cancer	0.000538	0.0231	CbGeAlD
Albendazole—CYP1A1—blood—hematologic cancer	0.00053	0.0228	CbGeAlD
Albendazole—TUBA1A—Tretinoin—Alitretinoin—hematologic cancer	0.000508	0.129	CbGdCrCtD
Albendazole—TUBA1A—Isotretinoin—Alitretinoin—hematologic cancer	0.000508	0.129	CbGdCrCtD
Albendazole—CYP1A2—lung—hematologic cancer	0.000471	0.0203	CbGeAlD
Albendazole—CYP1A1—lung—hematologic cancer	0.000465	0.02	CbGeAlD
Albendazole—ABCB1—hematopoietic system—hematologic cancer	0.000416	0.0179	CbGeAlD
Albendazole—CYP3A4—blood—hematologic cancer	0.000389	0.0168	CbGeAlD
Albendazole—CYP1A1—lymph node—hematologic cancer	0.000318	0.0137	CbGeAlD
Albendazole—ABCB1—gonad—hematologic cancer	0.000316	0.0136	CbGeAlD
Albendazole—ABCB1—blood—hematologic cancer	0.000275	0.0119	CbGeAlD
Albendazole—ABCB1—bone marrow—hematologic cancer	0.000267	0.0115	CbGeAlD
Albendazole—ABCB1—lung—hematologic cancer	0.000242	0.0104	CbGeAlD
Albendazole—ABCB1—testis—hematologic cancer	0.000228	0.00981	CbGeAlD
Albendazole—TUBA1A—Azacitidine—Pentostatin—hematologic cancer	0.000196	0.0501	CbGdCrCtD
Albendazole—TUBA1A—Azacitidine—Clofarabine—hematologic cancer	0.000175	0.0446	CbGdCrCtD
Albendazole—ABCB1—lymph node—hematologic cancer	0.000165	0.00711	CbGeAlD
Albendazole—TUBA1A—Azacitidine—Nelarabine—hematologic cancer	0.000165	0.042	CbGdCrCtD
Albendazole—TUBA1A—Azacitidine—Fludarabine—hematologic cancer	0.000129	0.0328	CbGdCrCtD
Albendazole—TUBA1A—Azacitidine—Gemcitabine—hematologic cancer	0.000121	0.0309	CbGdCrCtD
Albendazole—TUBA1A—Azacitidine—Cytarabine—hematologic cancer	0.000121	0.0309	CbGdCrCtD
Albendazole—TUBA1A—Azacitidine—Cladribine—hematologic cancer	0.000118	0.0302	CbGdCrCtD
Albendazole—Dermatitis—Hydroxyurea—hematologic cancer	8.76e-05	0.000561	CcSEcCtD
Albendazole—Urticaria—Ifosfamide—hematologic cancer	8.74e-05	0.00056	CcSEcCtD
Albendazole—Headache—Hydroxyurea—hematologic cancer	8.71e-05	0.000558	CcSEcCtD
Albendazole—Abdominal pain—Ifosfamide—hematologic cancer	8.7e-05	0.000557	CcSEcCtD
Albendazole—Body temperature increased—Ifosfamide—hematologic cancer	8.7e-05	0.000557	CcSEcCtD
Albendazole—Pancytopenia—Methotrexate—hematologic cancer	8.69e-05	0.000557	CcSEcCtD
Albendazole—Vertigo—Triamcinolone—hematologic cancer	8.68e-05	0.000556	CcSEcCtD
Albendazole—Hypersensitivity—Thalidomide—hematologic cancer	8.62e-05	0.000552	CcSEcCtD
Albendazole—Nausea—Melphalan—hematologic cancer	8.61e-05	0.000551	CcSEcCtD
Albendazole—Dizziness—Bortezomib—hematologic cancer	8.58e-05	0.000549	CcSEcCtD
Albendazole—Neutropenia—Methotrexate—hematologic cancer	8.56e-05	0.000548	CcSEcCtD
Albendazole—Gastrointestinal pain—Mitoxantrone—hematologic cancer	8.54e-05	0.000547	CcSEcCtD
Albendazole—Gastrointestinal pain—Irinotecan—hematologic cancer	8.54e-05	0.000547	CcSEcCtD
Albendazole—Thrombocytopenia—Etoposide—hematologic cancer	8.51e-05	0.000545	CcSEcCtD
Albendazole—Body temperature increased—Vincristine—hematologic cancer	8.48e-05	0.000543	CcSEcCtD
Albendazole—Abdominal pain—Vincristine—hematologic cancer	8.48e-05	0.000543	CcSEcCtD
Albendazole—Liver function test abnormal—Doxorubicin—hematologic cancer	8.47e-05	0.000542	CcSEcCtD
Albendazole—Skin disorder—Etoposide—hematologic cancer	8.44e-05	0.00054	CcSEcCtD
Albendazole—Dizziness—Vinorelbine—hematologic cancer	8.38e-05	0.000536	CcSEcCtD
Albendazole—Nausea—Lenalidomide—hematologic cancer	8.37e-05	0.000536	CcSEcCtD
Albendazole—Urticaria—Mitoxantrone—hematologic cancer	8.3e-05	0.000531	CcSEcCtD
Albendazole—Hypersensitivity—Carmustine—hematologic cancer	8.28e-05	0.00053	CcSEcCtD
Albendazole—Body temperature increased—Irinotecan—hematologic cancer	8.26e-05	0.000529	CcSEcCtD
Albendazole—Body temperature increased—Mitoxantrone—hematologic cancer	8.26e-05	0.000529	CcSEcCtD
Albendazole—Abdominal pain—Irinotecan—hematologic cancer	8.26e-05	0.000529	CcSEcCtD
Albendazole—Abdominal pain—Mitoxantrone—hematologic cancer	8.26e-05	0.000529	CcSEcCtD
Albendazole—Nausea—Hydroxyurea—hematologic cancer	8.26e-05	0.000529	CcSEcCtD
Albendazole—Vomiting—Bortezomib—hematologic cancer	8.25e-05	0.000528	CcSEcCtD
Albendazole—Hypersensitivity—Alitretinoin—hematologic cancer	8.2e-05	0.000525	CcSEcCtD
Albendazole—Vomiting—Bleomycin—hematologic cancer	8.19e-05	0.000524	CcSEcCtD
Albendazole—Rash—Bortezomib—hematologic cancer	8.18e-05	0.000524	CcSEcCtD
Albendazole—Dermatitis—Bortezomib—hematologic cancer	8.17e-05	0.000523	CcSEcCtD
Albendazole—Pancytopenia—Epirubicin—hematologic cancer	8.14e-05	0.000521	CcSEcCtD
Albendazole—Headache—Bortezomib—hematologic cancer	8.13e-05	0.00052	CcSEcCtD
Albendazole—Rash—Bleomycin—hematologic cancer	8.12e-05	0.00052	CcSEcCtD
Albendazole—Dermatitis—Bleomycin—hematologic cancer	8.11e-05	0.000519	CcSEcCtD
Albendazole—Hypersensitivity—Ifosfamide—hematologic cancer	8.11e-05	0.000519	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Methotrexate—hematologic cancer	8.09e-05	0.000518	CcSEcCtD
Albendazole—Vomiting—Vinorelbine—hematologic cancer	8.05e-05	0.000516	CcSEcCtD
Albendazole—Body temperature increased—Gemcitabine—hematologic cancer	8.05e-05	0.000515	CcSEcCtD
Albendazole—Neutropenia—Epirubicin—hematologic cancer	8.01e-05	0.000513	CcSEcCtD
Albendazole—Dizziness—Thiotepa—hematologic cancer	8e-05	0.000512	CcSEcCtD
Albendazole—Rash—Vinorelbine—hematologic cancer	7.99e-05	0.000511	CcSEcCtD
Albendazole—Dermatitis—Vinorelbine—hematologic cancer	7.98e-05	0.000511	CcSEcCtD
Albendazole—Headache—Vinorelbine—hematologic cancer	7.94e-05	0.000508	CcSEcCtD
Albendazole—Immune system disorder—Prednisone—hematologic cancer	7.92e-05	0.000507	CcSEcCtD
Albendazole—Hypersensitivity—Vincristine—hematologic cancer	7.9e-05	0.000506	CcSEcCtD
Albendazole—Vertigo—Betamethasone—hematologic cancer	7.87e-05	0.000504	CcSEcCtD
Albendazole—Vertigo—Dexamethasone—hematologic cancer	7.87e-05	0.000504	CcSEcCtD
Albendazole—Alopecia—Prednisone—hematologic cancer	7.75e-05	0.000496	CcSEcCtD
Albendazole—Dizziness—Thalidomide—hematologic cancer	7.74e-05	0.000495	CcSEcCtD
Albendazole—Hepatobiliary disease—Methotrexate—hematologic cancer	7.72e-05	0.000494	CcSEcCtD
Albendazole—Nausea—Bortezomib—hematologic cancer	7.71e-05	0.000493	CcSEcCtD
Albendazole—Hypersensitivity—Irinotecan—hematologic cancer	7.7e-05	0.000493	CcSEcCtD
Albendazole—Hypersensitivity—Mitoxantrone—hematologic cancer	7.7e-05	0.000493	CcSEcCtD
Albendazole—Vomiting—Thiotepa—hematologic cancer	7.69e-05	0.000493	CcSEcCtD
Albendazole—Nausea—Bleomycin—hematologic cancer	7.65e-05	0.00049	CcSEcCtD
Albendazole—Rash—Thiotepa—hematologic cancer	7.63e-05	0.000488	CcSEcCtD
Albendazole—Dermatitis—Thiotepa—hematologic cancer	7.62e-05	0.000488	CcSEcCtD
Albendazole—Agranulocytosis—Methotrexate—hematologic cancer	7.62e-05	0.000488	CcSEcCtD
Albendazole—Headache—Thiotepa—hematologic cancer	7.58e-05	0.000485	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	7.57e-05	0.000485	CcSEcCtD
Albendazole—Pancytopenia—Doxorubicin—hematologic cancer	7.53e-05	0.000482	CcSEcCtD
Albendazole—Nausea—Vinorelbine—hematologic cancer	7.52e-05	0.000482	CcSEcCtD
Albendazole—Body temperature increased—Cisplatin—hematologic cancer	7.5e-05	0.00048	CcSEcCtD
Albendazole—Vomiting—Thalidomide—hematologic cancer	7.44e-05	0.000476	CcSEcCtD
Albendazole—Dizziness—Carmustine—hematologic cancer	7.43e-05	0.000476	CcSEcCtD
Albendazole—Neutropenia—Doxorubicin—hematologic cancer	7.41e-05	0.000475	CcSEcCtD
Albendazole—Rash—Thalidomide—hematologic cancer	7.38e-05	0.000472	CcSEcCtD
Albendazole—Dermatitis—Thalidomide—hematologic cancer	7.37e-05	0.000472	CcSEcCtD
Albendazole—Dizziness—Alitretinoin—hematologic cancer	7.36e-05	0.000471	CcSEcCtD
Albendazole—Headache—Thalidomide—hematologic cancer	7.33e-05	0.000469	CcSEcCtD
Albendazole—Hepatitis—Methotrexate—hematologic cancer	7.33e-05	0.000469	CcSEcCtD
Albendazole—Dizziness—Ifosfamide—hematologic cancer	7.28e-05	0.000466	CcSEcCtD
Albendazole—Urinary tract disorder—Methotrexate—hematologic cancer	7.24e-05	0.000463	CcSEcCtD
Albendazole—Hepatobiliary disease—Epirubicin—hematologic cancer	7.22e-05	0.000463	CcSEcCtD
Albendazole—Nausea—Thiotepa—hematologic cancer	7.19e-05	0.00046	CcSEcCtD
Albendazole—Urethral disorder—Methotrexate—hematologic cancer	7.18e-05	0.00046	CcSEcCtD
Albendazole—Vomiting—Carmustine—hematologic cancer	7.15e-05	0.000458	CcSEcCtD
Albendazole—Agranulocytosis—Epirubicin—hematologic cancer	7.13e-05	0.000456	CcSEcCtD
Albendazole—Gastrointestinal pain—Etoposide—hematologic cancer	7.11e-05	0.000455	CcSEcCtD
Albendazole—Dizziness—Vincristine—hematologic cancer	7.09e-05	0.000454	CcSEcCtD
Albendazole—Rash—Carmustine—hematologic cancer	7.09e-05	0.000454	CcSEcCtD
Albendazole—Dermatitis—Carmustine—hematologic cancer	7.08e-05	0.000453	CcSEcCtD
Albendazole—Vomiting—Alitretinoin—hematologic cancer	7.08e-05	0.000453	CcSEcCtD
Albendazole—Headache—Carmustine—hematologic cancer	7.04e-05	0.000451	CcSEcCtD
Albendazole—Rash—Alitretinoin—hematologic cancer	7.02e-05	0.000449	CcSEcCtD
Albendazole—Dermatitis—Alitretinoin—hematologic cancer	7.01e-05	0.000449	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	7.01e-05	0.000449	CcSEcCtD
Albendazole—Thrombocytopenia—Betamethasone—hematologic cancer	7e-05	0.000448	CcSEcCtD
Albendazole—Thrombocytopenia—Dexamethasone—hematologic cancer	7e-05	0.000448	CcSEcCtD
Albendazole—Vomiting—Ifosfamide—hematologic cancer	7e-05	0.000448	CcSEcCtD
Albendazole—Hypersensitivity—Cisplatin—hematologic cancer	6.99e-05	0.000448	CcSEcCtD
Albendazole—Headache—Alitretinoin—hematologic cancer	6.97e-05	0.000447	CcSEcCtD
Albendazole—Nausea—Thalidomide—hematologic cancer	6.95e-05	0.000445	CcSEcCtD
Albendazole—Rash—Ifosfamide—hematologic cancer	6.94e-05	0.000444	CcSEcCtD
Albendazole—Dermatitis—Ifosfamide—hematologic cancer	6.93e-05	0.000444	CcSEcCtD
Albendazole—Erythema multiforme—Methotrexate—hematologic cancer	6.93e-05	0.000444	CcSEcCtD
Albendazole—Dizziness—Irinotecan—hematologic cancer	6.91e-05	0.000442	CcSEcCtD
Albendazole—Urticaria—Etoposide—hematologic cancer	6.9e-05	0.000442	CcSEcCtD
Albendazole—Body temperature increased—Etoposide—hematologic cancer	6.87e-05	0.00044	CcSEcCtD
Albendazole—Abdominal pain—Etoposide—hematologic cancer	6.87e-05	0.00044	CcSEcCtD
Albendazole—Vertigo—Prednisone—hematologic cancer	6.86e-05	0.000439	CcSEcCtD
Albendazole—Hepatitis—Epirubicin—hematologic cancer	6.86e-05	0.000439	CcSEcCtD
Albendazole—Vomiting—Vincristine—hematologic cancer	6.82e-05	0.000437	CcSEcCtD
Albendazole—Urticaria—Prednisolone—hematologic cancer	6.81e-05	0.000436	CcSEcCtD
Albendazole—Urinary tract disorder—Epirubicin—hematologic cancer	6.77e-05	0.000434	CcSEcCtD
Albendazole—Rash—Vincristine—hematologic cancer	6.76e-05	0.000433	CcSEcCtD
Albendazole—Dermatitis—Vincristine—hematologic cancer	6.76e-05	0.000433	CcSEcCtD
Albendazole—Urethral disorder—Epirubicin—hematologic cancer	6.72e-05	0.00043	CcSEcCtD
Albendazole—Headache—Vincristine—hematologic cancer	6.72e-05	0.00043	CcSEcCtD
Albendazole—Hepatobiliary disease—Doxorubicin—hematologic cancer	6.68e-05	0.000428	CcSEcCtD
Albendazole—Nausea—Carmustine—hematologic cancer	6.68e-05	0.000427	CcSEcCtD
Albendazole—Vomiting—Irinotecan—hematologic cancer	6.64e-05	0.000425	CcSEcCtD
Albendazole—Vomiting—Mitoxantrone—hematologic cancer	6.64e-05	0.000425	CcSEcCtD
Albendazole—Immune system disorder—Methotrexate—hematologic cancer	6.62e-05	0.000424	CcSEcCtD
Albendazole—Nausea—Alitretinoin—hematologic cancer	6.61e-05	0.000423	CcSEcCtD
Albendazole—Agranulocytosis—Doxorubicin—hematologic cancer	6.6e-05	0.000422	CcSEcCtD
Albendazole—Rash—Irinotecan—hematologic cancer	6.59e-05	0.000422	CcSEcCtD
Albendazole—Rash—Mitoxantrone—hematologic cancer	6.59e-05	0.000422	CcSEcCtD
Albendazole—Dermatitis—Mitoxantrone—hematologic cancer	6.58e-05	0.000421	CcSEcCtD
Albendazole—Dermatitis—Irinotecan—hematologic cancer	6.58e-05	0.000421	CcSEcCtD
Albendazole—Headache—Mitoxantrone—hematologic cancer	6.55e-05	0.000419	CcSEcCtD
Albendazole—Headache—Irinotecan—hematologic cancer	6.55e-05	0.000419	CcSEcCtD
Albendazole—Nausea—Ifosfamide—hematologic cancer	6.54e-05	0.000418	CcSEcCtD
Albendazole—Erythema multiforme—Epirubicin—hematologic cancer	6.48e-05	0.000415	CcSEcCtD
Albendazole—Alopecia—Methotrexate—hematologic cancer	6.47e-05	0.000415	CcSEcCtD
Albendazole—Vomiting—Gemcitabine—hematologic cancer	6.47e-05	0.000414	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	6.45e-05	0.000413	CcSEcCtD
Albendazole—Rash—Gemcitabine—hematologic cancer	6.42e-05	0.000411	CcSEcCtD
Albendazole—Dermatitis—Gemcitabine—hematologic cancer	6.41e-05	0.00041	CcSEcCtD
Albendazole—Hypersensitivity—Etoposide—hematologic cancer	6.4e-05	0.00041	CcSEcCtD
Albendazole—Headache—Gemcitabine—hematologic cancer	6.38e-05	0.000408	CcSEcCtD
Albendazole—Nausea—Vincristine—hematologic cancer	6.37e-05	0.000408	CcSEcCtD
Albendazole—Hepatitis—Doxorubicin—hematologic cancer	6.34e-05	0.000406	CcSEcCtD
Albendazole—Hypersensitivity—Prednisolone—hematologic cancer	6.32e-05	0.000404	CcSEcCtD
Albendazole—Urinary tract disorder—Doxorubicin—hematologic cancer	6.27e-05	0.000401	CcSEcCtD
Albendazole—Urticaria—Triamcinolone—hematologic cancer	6.26e-05	0.000401	CcSEcCtD
Albendazole—Body temperature increased—Triamcinolone—hematologic cancer	6.23e-05	0.000399	CcSEcCtD
Albendazole—Urethral disorder—Doxorubicin—hematologic cancer	6.22e-05	0.000398	CcSEcCtD
Albendazole—Nausea—Irinotecan—hematologic cancer	6.21e-05	0.000397	CcSEcCtD
Albendazole—Nausea—Mitoxantrone—hematologic cancer	6.21e-05	0.000397	CcSEcCtD
Albendazole—Immune system disorder—Epirubicin—hematologic cancer	6.19e-05	0.000397	CcSEcCtD
Albendazole—Alopecia—Epirubicin—hematologic cancer	6.06e-05	0.000388	CcSEcCtD
Albendazole—Skin disorder—Prednisone—hematologic cancer	6.05e-05	0.000387	CcSEcCtD
Albendazole—Nausea—Gemcitabine—hematologic cancer	6.05e-05	0.000387	CcSEcCtD
Albendazole—Vomiting—Cisplatin—hematologic cancer	6.03e-05	0.000386	CcSEcCtD
Albendazole—Erythema multiforme—Doxorubicin—hematologic cancer	6e-05	0.000384	CcSEcCtD
Albendazole—Rash—Cisplatin—hematologic cancer	5.98e-05	0.000383	CcSEcCtD
Albendazole—Dermatitis—Cisplatin—hematologic cancer	5.98e-05	0.000383	CcSEcCtD
Albendazole—Gastrointestinal pain—Betamethasone—hematologic cancer	5.85e-05	0.000374	CcSEcCtD
Albendazole—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.85e-05	0.000374	CcSEcCtD
Albendazole—Hypersensitivity—Triamcinolone—hematologic cancer	5.81e-05	0.000372	CcSEcCtD
Albendazole—Dizziness—Etoposide—hematologic cancer	5.75e-05	0.000368	CcSEcCtD
Albendazole—Immune system disorder—Doxorubicin—hematologic cancer	5.73e-05	0.000367	CcSEcCtD
Albendazole—Vertigo—Methotrexate—hematologic cancer	5.73e-05	0.000367	CcSEcCtD
Albendazole—Leukopenia—Methotrexate—hematologic cancer	5.71e-05	0.000366	CcSEcCtD
Albendazole—Urticaria—Dexamethasone—hematologic cancer	5.68e-05	0.000364	CcSEcCtD
Albendazole—Urticaria—Betamethasone—hematologic cancer	5.68e-05	0.000364	CcSEcCtD
Albendazole—Dizziness—Prednisolone—hematologic cancer	5.67e-05	0.000363	CcSEcCtD
Albendazole—Abdominal pain—Betamethasone—hematologic cancer	5.65e-05	0.000362	CcSEcCtD
Albendazole—Body temperature increased—Dexamethasone—hematologic cancer	5.65e-05	0.000362	CcSEcCtD
Albendazole—Body temperature increased—Betamethasone—hematologic cancer	5.65e-05	0.000362	CcSEcCtD
Albendazole—Abdominal pain—Dexamethasone—hematologic cancer	5.65e-05	0.000362	CcSEcCtD
Albendazole—Nausea—Cisplatin—hematologic cancer	5.63e-05	0.000361	CcSEcCtD
Albendazole—Alopecia—Doxorubicin—hematologic cancer	5.61e-05	0.000359	CcSEcCtD
Albendazole—Vomiting—Etoposide—hematologic cancer	5.53e-05	0.000354	CcSEcCtD
Albendazole—Rash—Etoposide—hematologic cancer	5.48e-05	0.000351	CcSEcCtD
Albendazole—Dermatitis—Etoposide—hematologic cancer	5.47e-05	0.000351	CcSEcCtD
Albendazole—Headache—Etoposide—hematologic cancer	5.44e-05	0.000349	CcSEcCtD
Albendazole—Rash—Prednisolone—hematologic cancer	5.4e-05	0.000346	CcSEcCtD
Albendazole—Dermatitis—Prednisolone—hematologic cancer	5.4e-05	0.000346	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.39e-05	0.000345	CcSEcCtD
Albendazole—Headache—Prednisolone—hematologic cancer	5.37e-05	0.000344	CcSEcCtD
Albendazole—Vertigo—Epirubicin—hematologic cancer	5.36e-05	0.000343	CcSEcCtD
Albendazole—Leukopenia—Epirubicin—hematologic cancer	5.34e-05	0.000342	CcSEcCtD
Albendazole—Dizziness—Triamcinolone—hematologic cancer	5.21e-05	0.000334	CcSEcCtD
Albendazole—Nausea—Etoposide—hematologic cancer	5.16e-05	0.000331	CcSEcCtD
Albendazole—Thrombocytopenia—Methotrexate—hematologic cancer	5.1e-05	0.000326	CcSEcCtD
Albendazole—Gastrointestinal pain—Prednisone—hematologic cancer	5.09e-05	0.000326	CcSEcCtD
Albendazole—Nausea—Prednisolone—hematologic cancer	5.09e-05	0.000326	CcSEcCtD
Albendazole—Skin disorder—Methotrexate—hematologic cancer	5.06e-05	0.000324	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.05e-05	0.000323	CcSEcCtD
Albendazole—Vomiting—Triamcinolone—hematologic cancer	5.01e-05	0.000321	CcSEcCtD
Albendazole—Rash—Triamcinolone—hematologic cancer	4.97e-05	0.000318	CcSEcCtD
Albendazole—Dermatitis—Triamcinolone—hematologic cancer	4.97e-05	0.000318	CcSEcCtD
Albendazole—Vertigo—Doxorubicin—hematologic cancer	4.96e-05	0.000318	CcSEcCtD
Albendazole—Urticaria—Prednisone—hematologic cancer	4.95e-05	0.000317	CcSEcCtD
Albendazole—Leukopenia—Doxorubicin—hematologic cancer	4.94e-05	0.000317	CcSEcCtD
Albendazole—Headache—Triamcinolone—hematologic cancer	4.94e-05	0.000316	CcSEcCtD
Albendazole—Abdominal pain—Prednisone—hematologic cancer	4.92e-05	0.000315	CcSEcCtD
Albendazole—Body temperature increased—Prednisone—hematologic cancer	4.92e-05	0.000315	CcSEcCtD
Albendazole—Thrombocytopenia—Epirubicin—hematologic cancer	4.77e-05	0.000305	CcSEcCtD
Albendazole—Skin disorder—Epirubicin—hematologic cancer	4.73e-05	0.000303	CcSEcCtD
Albendazole—Dizziness—Dexamethasone—hematologic cancer	4.73e-05	0.000303	CcSEcCtD
Albendazole—Dizziness—Betamethasone—hematologic cancer	4.73e-05	0.000303	CcSEcCtD
Albendazole—Nausea—Triamcinolone—hematologic cancer	4.68e-05	0.0003	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.67e-05	0.000299	CcSEcCtD
Albendazole—Hypersensitivity—Prednisone—hematologic cancer	4.59e-05	0.000294	CcSEcCtD
Albendazole—Vomiting—Dexamethasone—hematologic cancer	4.55e-05	0.000291	CcSEcCtD
Albendazole—Vomiting—Betamethasone—hematologic cancer	4.55e-05	0.000291	CcSEcCtD
Albendazole—Rash—Dexamethasone—hematologic cancer	4.51e-05	0.000289	CcSEcCtD
Albendazole—Rash—Betamethasone—hematologic cancer	4.51e-05	0.000289	CcSEcCtD
Albendazole—Dermatitis—Dexamethasone—hematologic cancer	4.51e-05	0.000288	CcSEcCtD
Albendazole—Dermatitis—Betamethasone—hematologic cancer	4.51e-05	0.000288	CcSEcCtD
Albendazole—Headache—Betamethasone—hematologic cancer	4.48e-05	0.000287	CcSEcCtD
Albendazole—Headache—Dexamethasone—hematologic cancer	4.48e-05	0.000287	CcSEcCtD
Albendazole—Thrombocytopenia—Doxorubicin—hematologic cancer	4.41e-05	0.000283	CcSEcCtD
Albendazole—Skin disorder—Doxorubicin—hematologic cancer	4.38e-05	0.00028	CcSEcCtD
Albendazole—Gastrointestinal pain—Methotrexate—hematologic cancer	4.26e-05	0.000273	CcSEcCtD
Albendazole—Nausea—Dexamethasone—hematologic cancer	4.25e-05	0.000272	CcSEcCtD
Albendazole—Nausea—Betamethasone—hematologic cancer	4.25e-05	0.000272	CcSEcCtD
Albendazole—Urticaria—Methotrexate—hematologic cancer	4.14e-05	0.000265	CcSEcCtD
Albendazole—Dizziness—Prednisone—hematologic cancer	4.12e-05	0.000264	CcSEcCtD
Albendazole—Body temperature increased—Methotrexate—hematologic cancer	4.12e-05	0.000263	CcSEcCtD
Albendazole—Abdominal pain—Methotrexate—hematologic cancer	4.12e-05	0.000263	CcSEcCtD
Albendazole—Gastrointestinal pain—Epirubicin—hematologic cancer	3.98e-05	0.000255	CcSEcCtD
Albendazole—Vomiting—Prednisone—hematologic cancer	3.96e-05	0.000254	CcSEcCtD
Albendazole—Rash—Prednisone—hematologic cancer	3.93e-05	0.000251	CcSEcCtD
Albendazole—Dermatitis—Prednisone—hematologic cancer	3.92e-05	0.000251	CcSEcCtD
Albendazole—Headache—Prednisone—hematologic cancer	3.9e-05	0.00025	CcSEcCtD
Albendazole—Urticaria—Epirubicin—hematologic cancer	3.87e-05	0.000248	CcSEcCtD
Albendazole—Abdominal pain—Epirubicin—hematologic cancer	3.85e-05	0.000247	CcSEcCtD
Albendazole—Body temperature increased—Epirubicin—hematologic cancer	3.85e-05	0.000247	CcSEcCtD
Albendazole—Hypersensitivity—Methotrexate—hematologic cancer	3.84e-05	0.000246	CcSEcCtD
Albendazole—Nausea—Prednisone—hematologic cancer	3.7e-05	0.000237	CcSEcCtD
Albendazole—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.69e-05	0.000236	CcSEcCtD
Albendazole—Hypersensitivity—Epirubicin—hematologic cancer	3.59e-05	0.00023	CcSEcCtD
Albendazole—Urticaria—Doxorubicin—hematologic cancer	3.58e-05	0.000229	CcSEcCtD
Albendazole—Abdominal pain—Doxorubicin—hematologic cancer	3.56e-05	0.000228	CcSEcCtD
Albendazole—Body temperature increased—Doxorubicin—hematologic cancer	3.56e-05	0.000228	CcSEcCtD
Albendazole—Dizziness—Methotrexate—hematologic cancer	3.44e-05	0.00022	CcSEcCtD
Albendazole—Hypersensitivity—Doxorubicin—hematologic cancer	3.32e-05	0.000213	CcSEcCtD
Albendazole—Vomiting—Methotrexate—hematologic cancer	3.31e-05	0.000212	CcSEcCtD
Albendazole—Rash—Methotrexate—hematologic cancer	3.28e-05	0.00021	CcSEcCtD
Albendazole—Dermatitis—Methotrexate—hematologic cancer	3.28e-05	0.00021	CcSEcCtD
Albendazole—Headache—Methotrexate—hematologic cancer	3.26e-05	0.000209	CcSEcCtD
Albendazole—Dizziness—Epirubicin—hematologic cancer	3.22e-05	0.000206	CcSEcCtD
Albendazole—Vomiting—Epirubicin—hematologic cancer	3.1e-05	0.000198	CcSEcCtD
Albendazole—Nausea—Methotrexate—hematologic cancer	3.09e-05	0.000198	CcSEcCtD
Albendazole—Rash—Epirubicin—hematologic cancer	3.07e-05	0.000197	CcSEcCtD
Albendazole—Dermatitis—Epirubicin—hematologic cancer	3.07e-05	0.000196	CcSEcCtD
Albendazole—Headache—Epirubicin—hematologic cancer	3.05e-05	0.000195	CcSEcCtD
Albendazole—Dizziness—Doxorubicin—hematologic cancer	2.98e-05	0.000191	CcSEcCtD
Albendazole—Nausea—Epirubicin—hematologic cancer	2.89e-05	0.000185	CcSEcCtD
Albendazole—Vomiting—Doxorubicin—hematologic cancer	2.87e-05	0.000184	CcSEcCtD
Albendazole—Rash—Doxorubicin—hematologic cancer	2.84e-05	0.000182	CcSEcCtD
Albendazole—Dermatitis—Doxorubicin—hematologic cancer	2.84e-05	0.000182	CcSEcCtD
Albendazole—Headache—Doxorubicin—hematologic cancer	2.82e-05	0.000181	CcSEcCtD
Albendazole—Nausea—Doxorubicin—hematologic cancer	2.68e-05	0.000171	CcSEcCtD
Albendazole—CYP1A1—Metabolism—AGRN—hematologic cancer	1.15e-05	0.000152	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.15e-05	0.000152	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GBA—hematologic cancer	1.15e-05	0.000152	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.15e-05	0.000152	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.15e-05	0.000152	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MYC—hematologic cancer	1.14e-05	0.000152	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ASNS—hematologic cancer	1.14e-05	0.000151	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—DCK—hematologic cancer	1.14e-05	0.000151	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—B3GAT1—hematologic cancer	1.14e-05	0.000151	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.11e-05	0.000147	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—FTCD—hematologic cancer	1.1e-05	0.000145	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GMPS—hematologic cancer	1.1e-05	0.000145	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PHYH—hematologic cancer	1.1e-05	0.000145	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—IDH2—hematologic cancer	1.09e-05	0.000144	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HMMR—hematologic cancer	1.09e-05	0.000144	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HDC—hematologic cancer	1.08e-05	0.000143	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTAP—hematologic cancer	1.05e-05	0.000139	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.05e-05	0.000139	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.03e-05	0.000136	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.03e-05	0.000136	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ARNTL—hematologic cancer	1.02e-05	0.000136	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1e-05	0.000133	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SMPD3—hematologic cancer	1e-05	0.000133	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1e-05	0.000133	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	9.99e-06	0.000132	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CA9—hematologic cancer	9.96e-06	0.000132	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ACP5—hematologic cancer	9.96e-06	0.000132	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CDA—hematologic cancer	9.86e-06	0.000131	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NCOR2—hematologic cancer	9.83e-06	0.00013	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	9.68e-06	0.000128	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	9.66e-06	0.000128	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.63e-06	0.000128	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PC—hematologic cancer	9.49e-06	0.000126	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	9.45e-06	0.000125	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TP53—hematologic cancer	9.39e-06	0.000124	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—IDH1—hematologic cancer	9.37e-06	0.000124	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—FHL2—hematologic cancer	9.36e-06	0.000124	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TXN—hematologic cancer	9.26e-06	0.000123	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCC3—hematologic cancer	9.26e-06	0.000123	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTO1—hematologic cancer	9.26e-06	0.000123	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	9.21e-06	0.000122	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AGRN—hematologic cancer	9.18e-06	0.000122	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GBA—hematologic cancer	9.16e-06	0.000121	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC35B2—hematologic cancer	9.16e-06	0.000121	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SPHK1—hematologic cancer	9.06e-06	0.00012	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	8.96e-06	0.000119	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—DCK—hematologic cancer	8.77e-06	0.000116	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—B3GAT1—hematologic cancer	8.77e-06	0.000116	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ASNS—hematologic cancer	8.77e-06	0.000116	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	8.72e-06	0.000116	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—UGT1A1—hematologic cancer	8.71e-06	0.000115	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—IDH2—hematologic cancer	8.7e-06	0.000115	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HMMR—hematologic cancer	8.7e-06	0.000115	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CRABP1—hematologic cancer	8.47e-06	0.000112	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC22A1—hematologic cancer	8.47e-06	0.000112	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTAP—hematologic cancer	8.38e-06	0.000111	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HDC—hematologic cancer	8.32e-06	0.00011	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALOX5—hematologic cancer	8.25e-06	0.000109	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	8.25e-06	0.000109	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ARNTL—hematologic cancer	8.18e-06	0.000108	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	8.03e-06	0.000106	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	8.01e-06	0.000106	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NUP98—hematologic cancer	7.99e-06	0.000106	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ACP5—hematologic cancer	7.96e-06	0.000105	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CA9—hematologic cancer	7.96e-06	0.000105	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NCOR2—hematologic cancer	7.85e-06	0.000104	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ADCY7—hematologic cancer	7.76e-06	0.000103	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NCOA3—hematologic cancer	7.76e-06	0.000103	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NUP214—hematologic cancer	7.71e-06	0.000102	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.63e-06	0.000101	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CDA—hematologic cancer	7.61e-06	0.000101	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCG2—hematologic cancer	7.55e-06	0.0001	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—MTR—hematologic cancer	7.55e-06	0.0001	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—IDH1—hematologic cancer	7.48e-06	9.91e-05	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	7.48e-06	9.91e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—FHL2—hematologic cancer	7.47e-06	9.9e-05	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	7.42e-06	9.83e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ENO2—hematologic cancer	7.4e-06	9.81e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTO1—hematologic cancer	7.4e-06	9.8e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TXN—hematologic cancer	7.4e-06	9.8e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ABCC3—hematologic cancer	7.4e-06	9.8e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AGRN—hematologic cancer	7.33e-06	9.71e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PC—hematologic cancer	7.32e-06	9.71e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SPHK1—hematologic cancer	7.24e-06	9.59e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTT1—hematologic cancer	7.18e-06	9.52e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GBA—hematologic cancer	7.07e-06	9.37e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.07e-06	9.37e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.07e-06	9.37e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SDC1—hematologic cancer	7.02e-06	9.3e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—UGT1A1—hematologic cancer	6.95e-06	9.22e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—IDH2—hematologic cancer	6.95e-06	9.2e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HMMR—hematologic cancer	6.95e-06	9.2e-05	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	6.81e-06	9.03e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC22A1—hematologic cancer	6.77e-06	8.97e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CRABP1—hematologic cancer	6.77e-06	8.97e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.7e-06	8.89e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.62e-06	8.77e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALOX5—hematologic cancer	6.59e-06	8.74e-05	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	6.59e-06	8.74e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.55e-06	8.68e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ARNTL—hematologic cancer	6.53e-06	8.65e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTAP—hematologic cancer	6.47e-06	8.57e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NUP98—hematologic cancer	6.39e-06	8.46e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CA9—hematologic cancer	6.35e-06	8.42e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ACP5—hematologic cancer	6.35e-06	8.42e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.33e-06	8.39e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NCOR2—hematologic cancer	6.27e-06	8.31e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ADCY7—hematologic cancer	6.2e-06	8.22e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NCOA3—hematologic cancer	6.2e-06	8.22e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NUP214—hematologic cancer	6.16e-06	8.16e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ABCG2—hematologic cancer	6.03e-06	7.99e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTR—hematologic cancer	6.03e-06	7.99e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—IDH1—hematologic cancer	5.97e-06	7.91e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NQO1—hematologic cancer	5.97e-06	7.91e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CD44—hematologic cancer	5.97e-06	7.91e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ENO2—hematologic cancer	5.91e-06	7.84e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TXN—hematologic cancer	5.91e-06	7.83e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCC3—hematologic cancer	5.91e-06	7.83e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTO1—hematologic cancer	5.91e-06	7.83e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.84e-06	7.74e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SPHK1—hematologic cancer	5.78e-06	7.66e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—FHL2—hematologic cancer	5.77e-06	7.64e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTT1—hematologic cancer	5.74e-06	7.6e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AGRN—hematologic cancer	5.65e-06	7.49e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYCS—hematologic cancer	5.65e-06	7.48e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HSP90AA1—hematologic cancer	5.61e-06	7.44e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SDC1—hematologic cancer	5.61e-06	7.43e-05	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.57e-06	7.38e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—UGT1A1—hematologic cancer	5.55e-06	7.36e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC22A1—hematologic cancer	5.4e-06	7.16e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CRABP1—hematologic cancer	5.4e-06	7.16e-05	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.37e-06	7.12e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—IDH2—hematologic cancer	5.36e-06	7.1e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMMR—hematologic cancer	5.36e-06	7.1e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.26e-06	6.98e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NUP98—hematologic cancer	5.1e-06	6.76e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.05e-06	6.69e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.04e-06	6.68e-05	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.03e-06	6.66e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTP1—hematologic cancer	4.98e-06	6.6e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.95e-06	6.56e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.95e-06	6.56e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NUP214—hematologic cancer	4.91e-06	6.51e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CA9—hematologic cancer	4.9e-06	6.5e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ACP5—hematologic cancer	4.9e-06	6.5e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.86e-06	6.44e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.84e-06	6.41e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.82e-06	6.38e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.81e-06	6.38e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTR—hematologic cancer	4.81e-06	6.38e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CD44—hematologic cancer	4.77e-06	6.32e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NQO1—hematologic cancer	4.77e-06	6.32e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ENO2—hematologic cancer	4.72e-06	6.26e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCB1—hematologic cancer	4.71e-06	6.24e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—IDH1—hematologic cancer	4.61e-06	6.11e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.58e-06	6.07e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NCOR1—hematologic cancer	4.57e-06	6.06e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTM1—hematologic cancer	4.57e-06	6.06e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.56e-06	6.04e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TXN—hematologic cancer	4.56e-06	6.04e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.56e-06	6.04e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYCS—hematologic cancer	4.51e-06	5.98e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.51e-06	5.98e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.48e-06	5.94e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SDC1—hematologic cancer	4.48e-06	5.93e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.46e-06	5.91e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.28e-06	5.68e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.27e-06	5.67e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.22e-06	5.59e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.17e-06	5.52e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.17e-06	5.52e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.06e-06	5.38e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—MTHFR—hematologic cancer	4.04e-06	5.36e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.04e-06	5.35e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTP1—hematologic cancer	3.98e-06	5.27e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NUP98—hematologic cancer	3.93e-06	5.21e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.82e-06	5.06e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.82e-06	5.06e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NQO1—hematologic cancer	3.81e-06	5.04e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CD44—hematologic cancer	3.81e-06	5.04e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NUP214—hematologic cancer	3.79e-06	5.03e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.73e-06	4.94e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTR—hematologic cancer	3.72e-06	4.92e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.72e-06	4.92e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTM1—hematologic cancer	3.65e-06	4.84e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NCOR1—hematologic cancer	3.65e-06	4.84e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ENO2—hematologic cancer	3.64e-06	4.83e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYCS—hematologic cancer	3.6e-06	4.77e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.58e-06	4.74e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.56e-06	4.72e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.53e-06	4.68e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SDC1—hematologic cancer	3.45e-06	4.58e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CG—hematologic cancer	3.4e-06	4.5e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTHFR—hematologic cancer	3.23e-06	4.28e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.22e-06	4.27e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.17e-06	4.21e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CREBBP—hematologic cancer	3.15e-06	4.17e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.07e-06	4.07e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCB1—hematologic cancer	3e-06	3.98e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CD—hematologic cancer	2.99e-06	3.96e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALB—hematologic cancer	2.95e-06	3.91e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NQO1—hematologic cancer	2.94e-06	3.89e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CD44—hematologic cancer	2.94e-06	3.89e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.92e-06	3.87e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.92e-06	3.87e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3R1—hematologic cancer	2.82e-06	3.74e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYCS—hematologic cancer	2.78e-06	3.68e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.76e-06	3.66e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.71e-06	3.6e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CB—hematologic cancer	2.6e-06	3.45e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.58e-06	3.42e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CREBBP—hematologic cancer	2.52e-06	3.33e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.45e-06	3.25e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.38e-06	3.16e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALB—hematologic cancer	2.35e-06	3.12e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.32e-06	3.07e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.27e-06	3.01e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.25e-06	2.98e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.25e-06	2.98e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.25e-06	2.98e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTEN—hematologic cancer	2.25e-06	2.98e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.17e-06	2.87e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—EP300—hematologic cancer	2.14e-06	2.84e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.08e-06	2.75e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.01e-06	2.66e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.99e-06	2.64e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.9e-06	2.52e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALB—hematologic cancer	1.88e-06	2.49e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.8e-06	2.38e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTEN—hematologic cancer	1.8e-06	2.38e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—EP300—hematologic cancer	1.71e-06	2.27e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.67e-06	2.22e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.66e-06	2.2e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CA—hematologic cancer	1.59e-06	2.1e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.55e-06	2.05e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.47e-06	1.95e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALB—hematologic cancer	1.45e-06	1.92e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTEN—hematologic cancer	1.43e-06	1.9e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.39e-06	1.84e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—EP300—hematologic cancer	1.37e-06	1.81e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKT1—hematologic cancer	1.3e-06	1.72e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.28e-06	1.7e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.27e-06	1.68e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTEN—hematologic cancer	1.11e-06	1.47e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—EP300—hematologic cancer	1.06e-06	1.4e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKT1—hematologic cancer	1.04e-06	1.37e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.01e-06	1.34e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKT1—hematologic cancer	8.26e-07	1.1e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.81e-07	1.03e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKT1—hematologic cancer	6.38e-07	8.45e-06	CbGpPWpGaD
